SELECTA BIOSCIENCES INC 4
4 · SELECTA BIOSCIENCES INC · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Siewers David
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-06-30$0.63/sh+7,420$4,675→ 7,420 total - Sale
Common Stock
2017-06-30$20.00/sh−7,420$148,405→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-06-30−7,420→ 2,194 totalExercise: $0.63Exp: 2020-09-06→ Common Stock (7,420 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]All shares underlying this option are fully vested.